Following a challenging two-year downturn, private biopharmaceutical venture financing saw a 20% ($3.8 million) increase in total deal value from 2023 to $22.4 million in
The Biosecure Act was left out of a key US defence bill that passed in the House this week, in a major win for Chinese
Representative image to depict Hemophilia World Day. Image credit: Getty Images/ AndreyPopov At the American Society of Hematology (ASH) Annual Meeting 2024, physicians looked back
Leading obesity drugmaker Lilly has announced a £279m ($365.5m) investment in the UK in a major collaboration between the company and the UK government. The
The prevailing treatment paradigm for newly diagnosed multiple myeloma (NDMM) patients who have received autologous stem cell transplantation (SCT) primarily consists of chemotherapy or Johnson
Pleural fluid cytology showing involvement by malignant cells of a mantle cell lymphoma, pleomorphic variant.. Image credit: Shutterstock/David A Litman Data from the Phase II
The respiratory syncytial virus (RSV) prophylaxis market across the eight major markets (8MM) – comprising the US, the five major European markets (France, Germany, Italy,
Investment for companies developing cell and gene therapies (CGTs) was discussed during the Genscript Biotech Global Forum London 2024 conference held on 20 November 2024.
On 26 September 2024, Cobenfy (KarXT) gained US Food and Drug Administration (FDA) approval as the first novel class of antipsychotics in decades. Developed by
As US President-Elect Donald Trump, who will return to the White House in late January 2025, appoints healthcare agency heads, industry insiders state that moods